Expand Energy Corporation Common Stock vs Vaxcyte Inc. Common Stock — how do they compare? Expand Energy Corporation Common Stock trades at $91.6 (market cap $21.38B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Expand Energy Corporation Common Stock is far larger — about 2× Vaxcyte Inc. Common Stock's market cap, and Expand Energy Corporation Common Stock pays a 2.49% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Expand Energy Corporation Common Stock for 0 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| EXE | PCVX | |
|---|---|---|
Market Cap | $21.38B | $10.51B |
Volume | 3,544,570 | 2,644,694 |
Sector | Energy | Health |
52-Week High | $122.89 | $73.82 |
52-Week Low | $84.09 | $40.32 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $24.45B | $9.14B |
Dividend Yield | 2.49% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Expand Energy Corporation is a US natural gas producer formed from the 2024 merger of Chesapeake Energy and Southwestern Energy, developing gas assets concentrated in the Appalachia and Haynesville basins.
Read more on EXE →Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →